Vancouver, British Columbia–(Newsfile Corp. – December 8, 2022) – Exploits Discovery Corp. (CSE: NFLD) (OTCQX: NFLDF) (FSE: 634) (“Exploits” or the “Company”) announces that, further to its news release of December 7, 2022, it has increased its Offering to up to a total of $4,410,000 from the previously announced $4,000,000. All other aspects of the Offering remain as disclosed in the December 7th news release.The Company intends to primarily use the net proceeds from this financing for exploration and drilling programs on its Bullseye claims.About Exploits Discovery Corp.Exploits is a Canadian mineral exploration company focused on the acquisition and development of mineral projects in Newfoundland and Labrador, Canada. The Company is actively exploring its gold projects in the Exploits Subzone, covering approximately 2,000 square kilometres of mineral tenements. The Company’s Exploration 2.0 methodology is focused on discovering high-grade structurally hosted epizonal gold similar to New Found Gold’s success at the Keats and Lotto Zones in the Appleton zone. Exploits is leveraging its local team and geologic understanding to become one of the most extensive explorers in the Exploits Subzone.ON BEHALF OF THE BOARD/s/ “Jeff Swinoga” President and CEOFor more information, please contact:Shanda KilbornVP, Investor Relations+1 (778) 819-2708investors@exploits.goldNeither the Canadian Securities Exchange nor its Regulation Service Provider (as the term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy of accuracy of this news release.Not for distribution to United States Newswire Services or for dissemination in the United StatesTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/147359
Researchers Develop Pioneering Method for Production of Antibodies as Revolutionary Alternative to Animal Experiments – vegconomist
Reading Time: 2 minutesA research team from Germany’s University Medical Greifswald Interfaculty Institute of Genetics and Functional Genome